During the past decade, Centro Médico Dra de Salvo conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 5 clinical trials were completed, i.e. on average, 16.1% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 3 clinical trials were completed. i.e. 11.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Médico Dra de Salvo" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "Amgen" with 3 trials sponsored, "Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & Co., Inc.)" with 2 trials sponsored and "Arena Pharmaceuticals" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Médico Dra de Salvo" #1 collaborator was "Dermira, Inc." with 1 trials as a collaborator and "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Centro Médico Dra de Salvo" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Chronic Obstructive Pulmonary Disease" (2 trials), "Heart Failure With Preserved Ejection Fraction" (2 trials), "Neoplasm Metastasis" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "Centro Médico Dra de Salvo" in a lesser frequency.

Most popular intervention types in "Centro Médico Dra de Salvo" are "Drug" (29 trials), "Biological" (5 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Lebrikizumab" (3 trials), "Abemaciclib" (2 trials), "Etrasimod" (2 trials) and "PRM-151 (Zinpentraxin Alfa)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Centro Médico Dra de Salvo" are 33 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Médico Dra de Salvo". undefined are not yet recruiting, 13 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 10 completed trials in Centro Médico Dra de Salvo, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Médico Dra de Salvo, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".